Systemic distribution and tumor localization of adoptively transferred lymphocytes in mice: Comparison with physiologically based pharmacokinetic model

Neoplasia

Volumn 4, Issue 1, 2002, Pages 3-8

  Melder, Robert J ^a   Munn, Lance L ^a   Stoll, Brian R ^a   Marecos, Edgardo M ^a   Baxter, Laurence T ^a   Weissleder, Ralph ^a   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Lymphocyte; Mathematical model; Pharmacokinetic; Trafficking; Tumor

Indexed keywords

8 QUINOLINOL INDIUM IN 111;

ADOPTIVE IMMUNOTHERAPY; ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CELLULAR IMMUNITY; FEMALE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; SPLENECTOMY; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR LOCALIZATION;

EID: 0036148001     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj/neo/7900209     Document Type: Article

References (36)

1. Progress in human tumor immunology and immunotherapy
2. The allogeneic response and tumor immunity
3. Dendritic cells: On the move from bench to bedside
4. Peptide based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein
5. p53 as a target for cancer vaccines: Recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge
6. In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from human prostate-specific antigen
7. Characteristics and in vivo homing of long- term T-cell lines and clones derived from tumor-draining lymph nodes
8. An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes
9. Immunohistological characterization of inflammatory cells that infiltrate tumors
10. Delivery of molecular medicine to solid tumors
11. Adoptive immunotherapy for cancer
12. The use of gene-modified tumor-filtrating lymphocytes for cancer therapy
13. The gene therapy of cancer
14. The immunotherapy and gene therapy of cancer
15. Localization of immune effector cells to tumor metastases
16. Antitumor effector cells: Extravasation and control of metastasis
17. Adoptive cellular therapy: Basic principles
18. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
19. Macrophage T lymphocyte interaction in the anti-tumor immune response: A mathematical model
20. Interaction between macrophages and T lymphocytes: Tumor sneaking through intrinsic to helper T cell dynamics
21. Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
22. The next frontier of molecular medicine: Delivery of therapeutics
23. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies
24. Tat peptide derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
25. Physiologically based kinetic model of effector cell biodistribution in mammals: Implications for adoptive immunotherapy
26. Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression
27. Preferential localization of human adherent lymphokine-activated killer cells in tumor microcirculation
28. Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors
29. Leukocyte-endothelial adhesion and angiogenesis in tumors
30. The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium
31. Endothelial vascular cell adhesion molecule 1 expression is suppressed by melanoma and carcinoma
32. A method for labeling cells for positron emission tomography (PET) studies
33. Imaging of activated natural killer cells in mice by positron emission tomography: Preferential uptake in tumors
34. Modulation of A-NK cell rigidity: In vitro characterization and in vivo implications for cell delivery
35. During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium